DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Cytokinetics Q4 EPS $(0.52) Misses $(0.44) Estimate, Sales $5.2M Miss $7.19M Estimate

Cytokinetics (NASDAQ:CYTK) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.44) by 18.18 percent. This is a 8.33 percent decrease over losses of $(0.48) per share from the

Benzinga · 03/03/2020 21:00

Cytokinetics (NASDAQ:CYTK) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.44) by 18.18 percent. This is a 8.33 percent decrease over losses of $(0.48) per share from the same period last year. The company reported quarterly sales of $5.2 million which missed the analyst consensus estimate of $7.19 million by 27.68 percent. This is a 44.55 percent decrease over sales of $9.377 million the same period last year.